Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer
- PMID: 32020607
- DOI: 10.1002/jcp.29517
Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer
Abstract
Breast carcinoma is one of the most commonly diagnosed tumors and also one of the deadliest cancers in the female. Long noncoding RNAs (lncRNAs) are emerging as novel targets and biomarkers for breast cancer diagnosis and treatment. In this study, we aimed to study the lncRNAs associated with the outcomes in patients using the breast invasive carcinoma datasets from The Cancer Genome Atlas. The Cox proportional hazards regression model was fitted to each lncRNA. Hierarchy clustering was carried out using these survival-related lncRNAs and the log-rank test was carried out for the clustered groups. DNA methylation status was utilized to identify the lncRNAs regulated by epigenetics. Finally, the coexpressed messenger RNA with the potential lncRNAs were utilized to study the possible functions and mechanisms of lncRNAs. In total, 182 lncRNAs had an impact on the survival time of the patients with a cutoff <0.01. The patients were clustered into three groups using these survival-related genes, which performed significantly different prognosis. Two lncRNAs, which were significantly correlated with the outcomes of breast cancer and were regulated by methylation status, were obtained. These two lncRNAs were TP53TG1 and RP5-1061H20.4. We proposed that TP53TG1 was activated by the wild-type TP53 and performed an impact on the PI3Ks family by binding YBX2 in breast cancer.
Keywords: TP53TG1; breast cancer; lncRNAs; survival analysis.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2. J Transl Med. 2018. PMID: 30261893 Free PMC article.
-
Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis.Sci Rep. 2022 Feb 7;12(1):1989. doi: 10.1038/s41598-022-05486-3. Sci Rep. 2022. PMID: 35132081 Free PMC article.
-
Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.Mol Med Rep. 2019 Jun;19(6):4697-4710. doi: 10.3892/mmr.2019.10165. Epub 2019 Apr 15. Mol Med Rep. 2019. PMID: 31059025 Free PMC article.
-
A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.Tumour Biol. 2016 Feb;37(2):1479-85. doi: 10.1007/s13277-015-4572-y. Epub 2015 Dec 11. Tumour Biol. 2016. PMID: 26662315 Review.
-
Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.Oncotarget. 2017 Jan 17;8(3):5508-5522. doi: 10.18632/oncotarget.12537. Oncotarget. 2017. PMID: 27732939 Free PMC article. Review.
Cited by
-
LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells.Front Genet. 2022 Oct 4;13:981030. doi: 10.3389/fgene.2022.981030. eCollection 2022. Front Genet. 2022. PMID: 36267418 Free PMC article.
-
Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.Breast Cancer. 2022 Nov;29(6):1050-1066. doi: 10.1007/s12282-022-01385-7. Epub 2022 Jul 24. Breast Cancer. 2022. PMID: 35871431
-
Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPF.Cell Death Dis. 2022 Jun 4;13(6):525. doi: 10.1038/s41419-022-04975-7. Cell Death Dis. 2022. PMID: 35661695 Free PMC article.
-
Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.Cell Cycle. 2022 Mar-Mar;21(6):572-584. doi: 10.1080/15384101.2022.2026705. Epub 2022 Jan 28. Cell Cycle. 2022. PMID: 35090377 Free PMC article.
-
Whole-genome-scale identification of novel non-protein-coding RNAs controlling cell proliferation and survival through a functional forward genetics strategy.Sci Rep. 2022 Jan 7;12(1):182. doi: 10.1038/s41598-021-03983-5. Sci Rep. 2022. PMID: 34997014 Free PMC article.
References
REFERENCES
-
- Beltran, A. S., Graves, L. M., & Blancafort, P. (2014). Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function. Oncogene, 33(39), 4767-4777.
-
- Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U., Mignotte, B., Le Floch, N., … Rincheval, V. (2014). Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F1F0-ATP synthase. Cell Cycle, 12(17), 2781-2793.
-
- Chen, X., Gao, Y., Li, D., Cao, Y., & Hao, B. (2017). LncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma. Journal of Cellular Biochemistry, 118(12), 4897-4904.
-
- Chiu, H.-S., Somvanshi, S., Patel, E., Chen, T.-W., Singh, V. P., Zorman, B., … Sood, A. K. (2018). Pan-Cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Reports, 23(1), 297-312.e12.
-
- DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014). Breast cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 64(1), 52-62.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
